Vaccination in Multiple Sclerosis: Friend or Foe?

Area of Science:

• Immunology
• Neurology
• Vaccinology

Background:

• Multiple sclerosis (MS) is a CNS disease impacting immune function.
• Disease-modifying treatments for MS carry risks like infections and altered vaccine efficacy.
• Vaccine hesitancy is growing, fueled by fears of neurological side effects.

Purpose of the Study:

• To review the immunology of vaccination in the context of MS.
• To discuss clinical considerations for vaccinating MS patients, especially those on immunosuppressants.
• To address concerns regarding vaccine-induced neurological disorders in MS.

Main Methods:

• Literature review on MS, vaccination, and immunosuppression.
• Analysis of immunological interactions between vaccines and the central nervous system.
• Discussion of clinical evidence and expert consensus.

Main Results:

• There is a consensus that vaccines do not cause MS (neither live nor inactivated).
• Live vaccines may elicit stronger reactions in immunocompromised MS patients.
• Vaccine effectiveness requires monitoring in MS patients on immunomodulatory/immunosuppressive therapy.

Conclusions:

• Vaccination is generally recommended for MS patients to reduce infection-related relapse risks.
• Careful consideration of vaccine type and patient immune status is crucial.
• Vaccination does not cause MS, but its protective effects may need monitoring during treatment.